Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

0RNK

Inventiva (0RNK)

Inventiva Sa
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:0RNK
DataHoraFonteTítuloCódigoCompanhia
18/03/202417:00UK RegulatoryInventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2DLSE:0RNKInventiva Sa
18/03/202417:00UK RegulatoryInventiva annonce les résultats positifs de l’essai clinique de Phase II, preuve de concept, LEGEND, combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de diabète de type 2LSE:0RNKInventiva Sa
13/03/202417:00UK RegulatoryInventiva to present the results of LEGEND Phase IIa combination trial with lanifibranor and empagliflozin in patients with MASH/NASH and T2DLSE:0RNKInventiva Sa
13/03/202417:00UK RegulatoryInventiva annonce la présentation des résultats de son étude clinique de Phase IIa LEGEND combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de DT2LSE:0RNKInventiva Sa
07/03/202418:00UK RegulatoryInventiva annonce la reprise du screening dans l’étude clinique de Phase III, NATiV3, évaluant lanifibranor dans la NASH  LSE:0RNKInventiva Sa
07/03/202418:00UK RegulatoryInventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumedLSE:0RNKInventiva Sa
15/02/202418:35UK RegulatoryInventiva publie ses informations financières préliminaires pour l’exercice fiscal 2023¹ et fait le point sur son étude clinique NATiV3LSE:0RNKInventiva Sa
15/02/202418:35UK RegulatoryInventiva reports preliminary 2023 fiscal year financial Information¹ and provides an update on its clinical trial NATiV3LSE:0RNKInventiva Sa
11/08/202003:00UK RegulatoryJefferies International Limited. Stabilisation NoticeLSE:0RNKInventiva Sa
23/08/201813:32UK RegulatoryJefferies International Limited. Sale of SharesLSE:0RNKInventiva Sa
 Apresentando as notícias mais relevantes sobre:LSE:0RNK